newsfilter
← Latest News
GlobeNewswire·

Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference

  • Wave Life Sciences Ltd. (NASDAQ: WVE) announced that President & CEO Paul Bolno, MD, MBA, will participate in an analyst-led fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference in New York City on Wednesday, May 20, 2026, at 8:00 a.m. ET.
  • A live webcast of the presentation will be available via the "Investor Events" section of the company's website, with a replay archived for a limited time.
  • Wave's PRISM® platform utilizes RNA-targeting modalities including RNAi (SpiNA) & RNA editing (AIMers) to treat rare & common disorders.
  • The company's pipeline includes clinical programs for obesity (WVE-007), alpha-1 antitrypsin deficiency (WVE-006), PNPLA3 I148M liver disease (WVE-008), Duchenne muscular dystrophy, & Huntington's disease.
  • Wave is headquartered in Cambridge, MA, & maintains contact points for Investor Relations & Media inquiries.